C43H53N5O8S
Neat
799,99
SOVAPREVIR; 1001667-23-7; ACH-0141625; 2ND9V3MN6O; DTXSID00142994; (2S, 4R)-N-[(1R, 2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-1-[(2S)-3, 3-dimethyl-2-(2-oxo-2-piperidin-1-ylethyl)butanoyl]-4-(7-methoxy-2-phenylquinolin-4-yl)oxypyrrolidine-2-carboxamide; sovaprevirum; (2S, 4R)-N-((1R, 2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl)-1-((2S)-3, 3-dimethyl-2-(2-oxo-2-piperidin-1-ylethyl)butanoyl)-4-(7-methoxy-2-phenylquinolin-4-yl)oxypyrrolidine-2-carboxamide; RefChem:1098899; DTXCID5065485; Sovaprevir [USAN]; ACH-1625; Sovaprevir (USAN); 2-Pyrrolidinecarboxamide, N-[(1R, 2S)-1-[[(cyclopropylsulfonyl)amino]carbonyl]-2-ethenylcyclopropyl]-1-[(2S)-3, 3-dimethyl-1-oxo-2-[2-oxo-2-(1-piperidinyl)ethyl]butyl]-4-[(7-methoxy-2-phenyl-4-quinolinyl)oxy]-, (2S and 4R)-; Sovaprevir [USAN:INN]; UNII-2ND9V3MN6O; SOVAPREVIR [INN]; Prodrug of ACH-1095; SOVAPREVIR [WHO-DD]; orb1699261
(2S, 4R)-N-[(1R, 2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-1-[(2S)-3 and 3-dimethyl-2-(2-oxo-2-piperidin-1-ylethyl)butanoyl]-4-(7-methoxy-2-phenylquinolin-4-yl)oxypyrrolidine-2-carboxamide
InChI=1S/C43H53N5O8S/c1-6-28-25-43(28,41(52)46-57(53,54)31-16-17-31)45-39(50)36-22-30(26-48(36)40(51)33(42(2,3)4)23-38(49)47-19-11-8-12-20-47)56-37-24-34(27-13-9-7-10-14-27)44-35-21-29(55-5)15-18-32(35)37/h6-7,9-10,13-15,18,21,24,28,30-31,33,36H,1,8,11-12,16-17,19-20,22-23,25-26H2,2-5H3,(H,45,50)(H,46,52)/t28-,30-,33-,36+,43-/m1/s1